Rajvir Dahiya is a Professor Emeritus of Urology Oncology at the University of California San Francisco School of Medicine (UCSF). He received his PhD in the field of Experimental Medicine (1978-1983) from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He did his post-doctoral fellowship training in oncology and molecular biology (1983-1987) at the University of Chicago Pritzker School of Medicine in Chicago, IL. After that he joined the University of California San Francisco School of Medicine (UCSF) and San Francisco Veterans Affairs Medical Center (VAMC) in 1987. Dahiya received his M.D. from the Kagoshima University Faculty of Medicine, Kagoshima, Japan and D.Sc. from the Osaka University Graduate School of Medicine, Osaka, Japan. Dahiya became director of the UCSF/VAMC Urology Research Center in 1991. After 34 years of service at the UCSF, he retired as a Professor Emeritus and Director of Urology Research Center. Also retired as a Senior Research Career Scientist from the Department of Veterans Affairs, Washington DC.

Dr. Dahiya served as a scientific reviewer and chairman (1996-2021) for the United States Army Department of Defense’s (DOD) medical research programs in prostate, breast and ovarian cancers. He was also a scientific reviewer and chairman (1992-2021) of scientific review committees for the National Institutes of Health (NIH) including the National Cancer Institute (NCI), the National Institutes of Digestive Diseases and Kidney (NIDDK) and the National Institute of Aging (NIA). He reviewed scientific progress and future plans for comprehensive cancer center programs, the George O’Brien Research Center, the NCI funded Specialized Program for Research Excellence (SPORE); postdoctoral fellow training programs; program projects related to oncology and research projects related to urologic oncology. Dr. Dahiya is a medical research advisor and scientific reviewer for numerous international programs and universities including institutions located in Europe, Israel, Japan Korea and Brazil. 

Dr. Dahiya was a scientific adviser to the President of India Dr. A.P.J. Abul Kalam (Avul Pakir Jainulabdeen Abdul Kalam, 11th President of India from 2002-2007). 

Dr. Dahiya has published more than 550 original research manuscripts in peer reviewed high impact journals and written several chapters in various books and holds multiple US patents in oncology. Dahiya’s world ranking in medicine is 4759 and USA ranking is 2644 with more than 37,000 research citations and D-index of 107 in 2024. He trained more than 100 post-doctoral fellows and visiting Professors during his career in the field of cancer etiology, pathophysiology, genetics, epigenetic, for understanding cancer initiation, progression and metastasis using various in vitro and in vivo models and pre-clinical models. Based on the NIH and VA data base NIH Reporter, Dahiya is awarded 99 times through his NIH/NCI/VA funded research projects. Dr. Dahiya was an Associate Editor of “CANCER RESEARCH” from 2000-2012. Currently, he is an Associate Editor of “CLINICAL CANCER RESEARCH” from 2012-present. He is also an Academic Editor of “PLoS ONE” from 2011-present and senior academic editor of “Amer J. Cancer Res” 2010-present. https://en.wikipedia.org/wiki/Rajvir_Dahiya